AdaptHealth Corp. $AHCO Shares Acquired by Public Sector Pension Investment Board

Public Sector Pension Investment Board lifted its holdings in shares of AdaptHealth Corp. (NASDAQ:AHCO) by 16.3% in the third quarter, HoldingsChannel reports. The firm owned 418,231 shares of the company’s stock after acquiring an additional 58,487 shares during the period. Public Sector Pension Investment Board’s holdings in AdaptHealth were worth $3,743,000 at the end of the most recent reporting period.

Other institutional investors have also recently modified their holdings of the company. AlphaQuest LLC lifted its stake in AdaptHealth by 275.7% in the 2nd quarter. AlphaQuest LLC now owns 3,941 shares of the company’s stock valued at $37,000 after buying an additional 2,892 shares in the last quarter. Assetmark Inc. increased its position in AdaptHealth by 87.6% during the second quarter. Assetmark Inc. now owns 5,529 shares of the company’s stock worth $52,000 after buying an additional 2,581 shares in the last quarter. Tower Research Capital LLC TRC raised its holdings in shares of AdaptHealth by 318.0% in the second quarter. Tower Research Capital LLC TRC now owns 9,592 shares of the company’s stock worth $90,000 after acquiring an additional 7,297 shares during the last quarter. Tidal Investments LLC purchased a new stake in shares of AdaptHealth in the second quarter valued at $96,000. Finally, CWM LLC lifted its position in shares of AdaptHealth by 1,562.1% in the second quarter. CWM LLC now owns 10,471 shares of the company’s stock valued at $99,000 after acquiring an additional 9,841 shares in the last quarter. 82.67% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at AdaptHealth

In other news, Director David Solomon Williams III sold 5,000 shares of the business’s stock in a transaction on Thursday, December 4th. The shares were sold at an average price of $9.43, for a total transaction of $47,150.00. Following the completion of the sale, the director directly owned 45,045 shares of the company’s stock, valued at $424,774.35. The trade was a 9.99% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 1.55% of the stock is currently owned by company insiders.

AdaptHealth Price Performance

AHCO opened at $10.34 on Friday. AdaptHealth Corp. has a 1 year low of $7.11 and a 1 year high of $11.63. The company’s 50 day simple moving average is $10.27 and its 200 day simple moving average is $9.66. The stock has a market capitalization of $1.40 billion, a PE ratio of 18.80, a P/E/G ratio of 1.14 and a beta of 1.72. The company has a debt-to-equity ratio of 1.09, a quick ratio of 0.86 and a current ratio of 1.08.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on AHCO. Wall Street Zen cut AdaptHealth from a “strong-buy” rating to a “buy” rating in a research report on Saturday, February 14th. Zacks Research raised shares of AdaptHealth from a “strong sell” rating to a “hold” rating in a research note on Thursday, January 1st. Canaccord Genuity Group boosted their price objective on shares of AdaptHealth from $14.00 to $15.00 and gave the company a “buy” rating in a research report on Thursday, November 6th. Finally, Weiss Ratings upgraded shares of AdaptHealth from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, January 30th. Four analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, AdaptHealth currently has an average rating of “Moderate Buy” and a consensus target price of $14.25.

AdaptHealth Company Profile

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.